Roundhill GLP-1 & Weight Loss ETF
OZEM
#2870
ETF Rang
€44.28 Mio.
Marktkapitalisierung
🇺🇸 US
Markt
26,68 €
Aktienkurs
-0.96%
Veränderung (1 Tag)
29.10%
Veränderung (1 Jahr)

Roundhill GLP-1 & Weight Loss ETF - Bestände

ETF-Bestände zum Stand 22. April 2026Anzahl der Bestände: 28

Vollständige Bestandsliste

Gewichtung %NameTickerGehaltene Aktien
15.55%
Eli Lilly & CoLLY9003
13.86%
Novo Nordisk A/SNVO183834
7.23%
Pfizer IncPFE138419
5.40%
Viking Therapeutics IncVKTX83569
5.32%
Innovent Biologics Inc1801 HK242500
5.03%
Ascletis Pharma Inc1672 HK1133000
4.00%
Roche Holding AGROP SW5146
3.80%
Amgen IncAMGN5762
3.68%
AstraZeneca PLCAZN9819
3.68%
Zealand Pharma A/SZEAL DC40685
3.67%
Hanmi Pharm Co Ltd128940 KS5593
3.42%
Chugai Pharmaceutical Co Ltd4519 JP32800
3.25%
Shanghai Fosun Pharmaceutical Group Co Ltd2196 HK662500
3.17%
Regeneron Pharmaceuticals IncREGN2218
2.84%
CSPC Pharmaceutical Group Ltd1093 HK1298000
2.33%
United Laboratories International Holdings Ltd/The3933 HK954000
2.28%
Gubra A/SGUBRA DC22723
2.27%
Structure Therapeutics IncGPCR25378
2.18%
MBX Biosciences IncMBX34264
1.80%
Gilead Sciences IncGILD7043
1.37%
Rhythm Pharmaceuticals IncRYTM8463
1.23%
Shionogi & Co Ltd4507 JP32700
1.06%
First American Government Obligations Fund 12/01/2031FGXXX553171.68
1.03%
Biohaven LtdBHVN53094
0.46%
WaVe Life Sciences LtdWVE32778
0.44%
Corbus Pharmaceuticals Holdings IncCRBP22131
0.17%
Cash & OtherCash&Other90698.75
-0.53%
SWISS FRANCCHF-215321.29